Browse Tag

Takeda Pharmaceuticals

Tekada will import 50 mln doses of Moderna’s coronavirus vaccine candidate in Japan

1 min read

The FINANCIAL — Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW). Moderna has previously announced that the 30,000 participant Phase 3 clinical trial of mRNA-1273 at the 100 µg dose level in the U.S. is fully enrolled. This follows Takeda’s recent announcement that it is establishing the capability to manufacture Novavax’ COVID‑19 vaccine candidate…

Read More »

Tekada will import 50 mln doses of Moderna’s coronavirus vaccine candidate in Japan

1 min read

The FINANCIAL — Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and…